U.S Class(es): 006, 018, 044, 046, 051, 052
Name | Novartis Pharma AG, |
---|---|
Address | Trademark Department Postfach CH-4002 Basel SWITZERLAND |
Date | Description | Action Tags | Code |
---|---|---|---|
Nov-12-2023 | TOTAL INVALIDATION PROCESSED BY THE IB | INNTP | |
Oct-25-2023 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | INTSP | |
Oct-25-2023 | INVALIDATION PROCESSED | INPCP | |
Oct-17-2023 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | INTRP | |
Feb-17-2023 | CANCELLED SECTION 71 | C71TO | |
Sep-23-2016 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Sep-02-2016 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
Sep-02-2016 | FINAL DISPOSITION PROCESSED | FIMPP | |
Sep-01-2016 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
Aug-02-2016 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
May-17-2016 | PUBLISHED FOR OPPOSITION | PUBOA | |
Apr-27-2016 | NOTICE OF PUBLICATION | NPUBO | |
Apr-12-2016 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
Apr-05-2016 | ASSIGNED TO EXAMINER | DOCKD | |
Mar-18-2016 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
Mar-14-2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
Mar-11-2016 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
Mar-10-2016 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | SDRCM |